Overexpression of polo-like kinase 1 and its clinical significance in human non-small cell lung cancer

International Journal of Biochemistry and Cell Biology

Volumn 44, Issue 1, 2012, Pages 200-210

  Wang, Zhao Xia ^a   Xue, Dong ^a   Liu, Zhi Li ^a   Lu, Bin Bin ^a   Bian, Hai Bo ^a   Pan, Xuan ^a   Yin, Yong Mei ^b  

^a THE SECOND AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Chemotherapy; Immunohistochemistry; Non small cell lung cancer; Polo like kinase 1; Prognosis; Radiotherapy; RNA interference

Indexed keywords

CASPASE 3; CDC25C PROTEIN; CELL PROTEIN; CYCLIN B1; CYCLIN DEPENDENT KINASE 1; DOCETAXEL; MESSENGER RNA; PACLITAXEL; POLO LIKE KINASE 1; PROTEIN BAX; PROTEIN P53; UNCLASSIFIED DRUG;

ADVANCED CANCER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER INHIBITION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL PROLIFERATION; CHEMOSENSITIVITY; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; NUDE MOUSE; PROGNOSIS; PROTEIN EXPRESSION; RADIATION DOSE;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, NON-SMALL-CELL LUNG; CELL CYCLE; CELL CYCLE PROTEINS; CELL LINE, TUMOR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; RNA INTERFERENCE; RNA, MESSENGER; TRANSFECTION; TUMOR MARKERS, BIOLOGICAL;

EID: 83555163938     PISSN: 13572725     EISSN: 18785875     Source Type: Journal    
DOI: 10.1016/j.biocel.2011.10.017     Document Type: Article

References (45)

1. K. Ando, T. Ozaki, H. Yamamoto, K. Furuya, M. Hosoda, and S. Hayashi Polo-like kinase 1 (Plk1) inhibits p53 function by physical interaction and phosphorylation J Biol Chem 279 2004 25549 25561 (Pubitemid 38756815)
2. V. Archambault, and D.M. Glover Polo-like kinases: conservation and divergence in their functions and regulation Nat Rev Mol Cell Biol 10 2009 265 275
3. P. Chopra, G. Sethi, S.G. Dastidar, and A. Ray Polo-like kinase inhibitors: an emerging opportunity for cancer therapeutics Expert Opin Investig Drugs 19 2010 27 43
4. J.P. Cogswell, C.E. Brown, J.E. Bisi, and S.D. Neill Dominant-negative polo-like kinase 1 induces mitotic catastrophe independent of cdc25C function Cell Growth Differ 11 2000 615 623 (Pubitemid 32042984)
5. W. Dai, and J.P. Cogswell Polo-like kinases and the microtubule organization center: targets for cancer therapies Prog Cell Cycle Res 5 2003 327 334
6. Y. Degenhardt, and T. Lampkin Targeting Polo-like kinase in cancer therapy Clin Cancer Res 16 2010 384 389
7. Y.B. Feng, D.C. Lin, Z.Z. Shi, X.C. Wang, X.M. Shen, and Y. Zhang Overexpression of PLK1 is associated with poor survival by inhibiting apoptosis via enhancement of survivin level in esophageal squamous cell carcinoma Int J Cancer 124 2009 578 588
8. Q. Gao, X. Huang, D. Tang, Y. Cao, G. Chen, and Y. Lu Influence of chk1 and plk1 silencing on radiation- or cisplatin-induced cytotoxicity in human malignant cells Apoptosis 11 2006 1789 1800 (Pubitemid 44371052)
9. K. Gerster, W. Shi, B. Ng, S. Yue, E. Ito, and J. Waldron Targeting polo-like kinase 1 enhances radiation efficacy for head-and-neck squamous cell carcinoma Int J Radiat Oncol Biol Phys 77 2010 253 260
10. D.M. Glover, I.M. Hagan, and A.A. Tavares Polo-like kinases: a team that plays throughout mitosis Genes Dev 12 1998 3777 3787 (Pubitemid 29024839)
11. R.M. Golsteyn, H.A. Lane, K.E. Mundt, L. Arnaud, and E.A. Nigg The family of polo-like kinases Prog Cell Cycle Res 2 1996 107 114
12. Z.L. He, H. Zheng, H. Lin, X.Y. Miao, and D.W. Zhong Overexpression of polo-like kinase1 predicts a poor prognosis in hepatocellular carcinoma patients World J Gastroenterol 15 2009 4177 4182
13. Y.J. Jang, Y.S. Kim, and W.H. Kim Oncogenic effect of Polo-like kinase 1 expression in human gastric carcinomas Int J Oncol 29 2006 589 594
14. A. Jimeno, B. Rubio-Viqueira, N.V. Rajeshkumar, A. Chan, A. Solomon, and M. Hidalgo A fine-needle aspirate-based vulnerability assay identifies polo-like kinase 1 as a mediator of gemcitabine resistance in pancreatic cancer Mol Cancer Ther 9 2010 311 318
15. S. Kanaji, H. Saito, S. Tsujitani, S. Matsumoto, S. Tatebe, and A. Kondo Expression of polo-like kinase 1 (PLK1) protein predicts the survival of patients with gastric carcinoma Oncology 70 2006 126 133 (Pubitemid 43760338)
16. L. Kneisel, K. Strebhardt, A. Bernd, M. Wolter, A. Binder, and R. Kaufmann Expression of polo-like kinase (PLK1) in thin melanomas: a novel marker of metastatic disease J Cutan Pathol 29 2002 354 358
17. H.A. Lane, and E.A. Nigg Antibody microinjection reveals an essential role for human polo-like kinase 1 (Plk1) in the functional maturation of mitotic centrosomes J Cell Biol 135 1996 1701 1713 (Pubitemid 27036434)
18. J.J. Li, and S.A. Li Mitotic kinases the key to duplication, segregation, and cytokinesis errors, chromosomal instability, and oncogenesis Pharmacol Ther 111 2006 974 984 (Pubitemid 44137383)
19. X. Liu, and R.L. Erikson Polo-like kinase (Plk)1 depletion induces apoptosis in cancer cells Proc Natl Acad Sci USA 100 2003 5789 5794 (Pubitemid 36576886)
20. C. McInnes, and M.D. Wyatt PLK1 as an oncology target: current status and future potential Drug Discov Today 16 2011 619 625
21. T. Okano-Uchida, E. Okumura, M. Iwashita, H. Yoshida, K. Tachibana, and T. Kishimoto Distinct regulators for Plk1 activation in starfish meiotic and early embryonic cycles EMBO J 22 2003 5633 5642 (Pubitemid 37279972)
22. P.J. Paddison, A.A. Caudy, E. Bernstein, G.J. Hannon, and D.S. Conklin Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells Genes Dev 16 2002 948 958 (Pubitemid 34408544)
23. A.G. Pallis, L. Serfass, R. Dziadziusko, J.P. van Meerbeeck, D. Fennell, and D. Lacombe Targeted therapies in the treatment of advanced/metastatic NSCLC Eur J Cancer 45 2009 2473 2487
24. F. Rödel, S. Keppner, G. Capalbo, R. Bashary, M. Kaufmann, and C. Rödel Polo-like kinase 1 as predictive marker and therapeutic target for radiotherapy in rectal cancer Am J Pathol 177 2010 918 929
25. T.L. Schmit, M.C. Ledesma, and N. Ahmad Modulating polo-like kinase 1 as a means for cancer chemoprevention Pharm Res 27 2010 989 998
26. T.L. Schmit, W. Zhong, M. Nihal, and N. Ahmad Polo-like kinase 1 (Plk1) in non-melanoma skin cancers Cell Cycle 8 2009 2697 2702
27. W. Shi, N.M. Alajez, C. Bastianutto, A.B. Hui, J.D. Mocanu, and E. Ito Significance of Plk1 regulation by miR-100 in human nasopharyngeal cancer Int J Cancer 126 2010 2036 2048
28. A.R. Siegel, E. Ward, T. Murray, J. Xu, C. Smigal, and M.J. Thun Cancer statistics CA Cancer J Clin 56 2006 106 130
29. M.R. Smith, M.L. Wilson, R. Hamanaka, D. Chase, H. Kung, and D.L. Longo Malignant transformation of mammalian cells initiated by constitutive expression of the polo-like kinase Biochem Biophys Res Commun 234 1997 397 405 (Pubitemid 27243915)
30. B. Spänkuch-Schmitt, J. Bereiter-Hahn, M. Kaufmann, and K. Strebhardt Effect of RNA silencing of polo-like kinase-1 (PLK1) on apoptosis and spindle formation in human cancer cells J Natl Cancer Inst 94 2002 1863 1877 (Pubitemid 36104631)
31. B. Spänkuch, and K. Strebhardt RNA interference-based gene silencing in mice: the development of a novel therapeutical strategy Curr Pharm Des 11 2005 3405 3419 (Pubitemid 41300767)
32. B. Spänkuch-Schmitt, G. Wolf, C. Solbach, S. Loibl, R. Knecht, and M. Stegmüller Downregulation of human polo-like kinase activity by antisense oligonucleotides induces growth inhibition in cancer cells Oncogene 21 2002 3162 3171 (Pubitemid 34548087)
33. K. Strebhardt, and A. Ullrich Targeting polo-like kinase 1 for cancer therapy Nat Rev Cancer 6 2006 321 330
34. T. Takahashi, B. Sano, T. Nagata, H. Kato, Y. Sugiyama, and K. Kunieda Polo-like kinase 1 (PLK1) is overexpressed in primary colorectal cancers Cancer Sci 94 2003 148 152 (Pubitemid 36575873)
35. N. Takai, R. Hamanaka, J. Yoshimatsu, and I. Miyakawa Polo-like kinases (Plks) and cancer Oncogene 24 2005 287 291 (Pubitemid 40188609)
36. S. Tyagi, K. Bhui, R. Singh, M. Singh, S. Raisuddin, and Y. Shukla Polo-like kinase1 (Plk1) knockdown enhances cisplatin chemosensitivity via up-regulation of p73α in p53 mutant human epidermoid squamous carcinoma cells Biochem Pharmacol 80 2010 1326 1334
37. M.A. van Vugt, and R.H. Medema Getting in and out of mitosis with Polo-like kinase-1 Oncogene 24 2005 2844 2859 (Pubitemid 40638094)
38. W. Weichert, C. Denkert, M. Schmidt, V. Gekeler, G. Wolf, and M. Köbel Polo-like kinase isoform expression is a prognostic factor in ovarian carcinoma Br J Cancer 90 2004 815 821 (Pubitemid 38406592)
39. W. Weichert, G. Kristiansen, M. Schmidt, V. Gekeler, A. Noske, and S. Niesporek Polo-like kinase 1 expression is a prognostic factor in human colon cancer World J Gastroenterol 11 2005 5644 5650 (Pubitemid 41684917)
40. W. Weichert, G. Kristiansen, K.J. Winzer, M. Schmidt, V. Gekeler, and A. Noske Polo-like kinase isoforms in breast cancer: expression patterns and prognostic implications Virchows Arch 446 2005 442 450 (Pubitemid 40674853)
41. W. Weichert, M. Schmidt, V. Gekeler, C. Denkert, C. Stephan, and K. Jung Polo-like kinase 1 is overexpressed in prostate cancer and linked to higher tumor grades Prostate 60 2004 240 245 (Pubitemid 38971835)
42. G. Wolf, R. Elez, A. Doermer, U. Holtrich, H. Ackermann, and H.J. Stutte Prognostic significance of polo-like kinase (PLK) expression in non-small cell lung cancer Oncogene 14 1997 543 549 (Pubitemid 27090956)
43. S. Xie, B. Xie, M.Y. Lee, and W. Dai Regulation of cell cycle checkpoints by polo-like kinases Oncogene 24 2005 277 286 (Pubitemid 40188608)
44. J. Yuan, A. Hörlin, B. Hock, H.J. Stutte, H. Rübsamen-Waigmann, and K. Strebhardt Polo-like kinase, a novel marker for cellular proliferation Am J Pathol 150 1997 1165 1172 (Pubitemid 27152634)
45. C. Zhao, L. Gong, W. Li, and L. Chen Overexpression of Plk1 promotes malignant progress in human esophageal squamous cell carcinoma J Cancer Res Clin Oncol 136 2010 9 16